Search research articles
Contact Us
Filters
Showing results (101-110 of 138) with videos related to
Page
of 14
Sort By:
Scientific Reports
|
July 16, 2017
Emergence of ON1 genotype of human respiratory syncytial virus subgroup A in China between 2011 and 2015
Jinhua Song, Yan Zhang, Huiling Wang, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 2018
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials
Preethi Krishnan, Tami Pilot-Matias, Gretja Schnell, et al.
Journal of Virology
|
May 7, 2002
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675
Akhteruzzaman Molla, Warren Kati, Robert Carrick, et al.
Antimicrobial Agents and Chemotherapy
|
August 3, 1999
Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein
C L Talarico, T C Burnette, W H Miller, et al.
Scientific Reports
|
December 3, 2017
Emergence of BA9 genotype of human respiratory syncytial virus subgroup B in China from 2006 to 2014
Jinhua Song, Huiling Wang, Jing Shi, et al.
Transplantation Proceedings
|
December 20, 2000
Liver transplantation is not contraindicated in infancy
K L Chan, S T Fan, H Saing, et al.
Transplantation Proceedings
|
December 20, 2000
Post liver transplantation stenosis of biliary-enteric anastomoses in infancy: diagnosis and treatment
K L Chan, S T Fan, H Saing, et al.
Asia-Pacific Journal of Public Health
|
May 10, 2021
Digital Health Literacy and Health-Related Well-Being Amid the COVID-19 Pandemic: The Role of Socioeconomic Status Among University Students in Hong Kong and Macao
Padmore Adusei Amoah, Angela Y M Leung, Laurence Lloyd Parial, et al.
Antimicrobial Agents and Chemotherapy
|
December 30, 2015
Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection
Eric J Lawitz, William D O'Riordan, Armen Asatryan, et al.
Antimicrobial Agents and Chemotherapy
|
February 15, 2017
<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir
Teresa I Ng, Preethi Krishnan, Tami Pilot-Matias, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 138) with videos related to
Sort By:
Page
of 14
Scientific Reports
|
July 16, 2017
Emergence of ON1 genotype of human respiratory syncytial virus subgroup A in China between 2011 and 2015
Jinhua Song, Yan Zhang, Huiling Wang, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 2018
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials
Preethi Krishnan, Tami Pilot-Matias, Gretja Schnell, et al.
Journal of Virology
|
May 7, 2002
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675
Akhteruzzaman Molla, Warren Kati, Robert Carrick, et al.
Antimicrobial Agents and Chemotherapy
|
August 3, 1999
Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein
C L Talarico, T C Burnette, W H Miller, et al.
Scientific Reports
|
December 3, 2017
Emergence of BA9 genotype of human respiratory syncytial virus subgroup B in China from 2006 to 2014
Jinhua Song, Huiling Wang, Jing Shi, et al.
Transplantation Proceedings
|
December 20, 2000
Liver transplantation is not contraindicated in infancy
K L Chan, S T Fan, H Saing, et al.
Transplantation Proceedings
|
December 20, 2000
Post liver transplantation stenosis of biliary-enteric anastomoses in infancy: diagnosis and treatment
K L Chan, S T Fan, H Saing, et al.
Asia-Pacific Journal of Public Health
|
May 10, 2021
Digital Health Literacy and Health-Related Well-Being Amid the COVID-19 Pandemic: The Role of Socioeconomic Status Among University Students in Hong Kong and Macao
Padmore Adusei Amoah, Angela Y M Leung, Laurence Lloyd Parial, et al.
Antimicrobial Agents and Chemotherapy
|
December 30, 2015
Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection
Eric J Lawitz, William D O'Riordan, Armen Asatryan, et al.
Antimicrobial Agents and Chemotherapy
|
February 15, 2017
<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir
Teresa I Ng, Preethi Krishnan, Tami Pilot-Matias, et al.
Page
of 14